Focuses on GI-Oncology, discussing innovative approaches and strategies for managing gastrointestinal cancers effectively.
The 4th Oncology Updates, 26th October 2024, concentrated on GI-Oncology, featuring the latest advancements in diagnosing gastrointestinal cancers. Experts discussed cutting-edge treatment options and management strategies aimed at improving patient outcomes and survival rates.
| Meetings : | Series 4 |
| Track : | Gastrointestinal Cancers |
| Type : | Virtual Mode |
| Time : | 05:30 PM to 09:30 PM IST |
Dr.Ghanashyam Biswas, Introduction and Context Setting for the webinar
Quiz-1 Lymphoma, Leukemia and Myeloma
CML - Newer Therapies
Pola – RCHP standard of care as First line
New frontiers in Multiple myeloma
Defining treatment landscape in Hodgkin's Lymphoma with Adcetris
Relapsed Hodgkins Lymphoma
Is CAR T cell the Final Say in relapsed Multiple Myeloma
BCL2 inhibitors in CLL : Diving deep into the data
Difficult to treat NHL
Optimizing treatment outcomes in IC-ineligible AML patients with BCL2 inhibitors
QUIZ Lymphoma, Leukemia and Myeloma
Inotuzumab based therapy can be used as a bridge to transplant in relapsed
Precision therapy in AML
Iron Iso Maltoside vs Other IV Iron
Vote of Thanks
The 2nd Oncology Updates, 1st December 2023, focused on Gastrointestinal (GI) Cancer, offering detailed insights into the latest diagnostic advancements. Experts also discussed new treatment options and the latest clinical research driving progress in the management of GI cancers.
| Meetings : | Series 2 |
| Track : | Gastrointestinal Cancers |
| Type : | Virtual Mode |
| Time : | 05:30 PM to 9:30 PM IST |
Dr. Soumya Surath Panda, Introduction and Context Setting for the webinar
Quiz Gastrointestinal cancer
Advancements in perioperative immunotherapy in upper GI cancer
Droplet vs Triplet in advanced Gastroesophageal cancer
Post progression Ramucirumab in advanced gastric cancer as logical approach?
Panel Discussion
Role of carbozantinib in advanced NETs
The PEGASUS trial: post- surgical liquid biopsy guided treatment of stage lIl and high-risk stage Il colon cancer patients
Panel Discussion
1L Unresectable HCC (Etiology) : Will this affect your systemic treatment selection ?
Radiotherapy free management of rectal cancer
Radiotherapy free management of rectal cancer
Panel Discussion
Newer Updates In The Management Of 1st Line BTC
Management Of Advanced Biliary Tract Cancer In The Current Era
Optimizing the results with ferric Carboxymaltose in iron deficiency anemia (Encicarb 750)
Quiz
Vote of Thanks